Fortrea Holdings (FTRE) Current Assets (2022 - 2026)
Fortrea Holdings (FTRE) posted Current Assets of $881.5 million for Q1 2026, down 1.75% on a QoQ basis from $897.2 million in Q4 2025, and down 9.15% year-over-year from $970.3 million in Q1 2025.
Fortrea Holdings (FTRE) Current Assets (2022 - 2026) Analysis & Trends
Fortrea Holdings' Current Assets history runs 5 years deep, the most recent figure standing at $881.5 million for Q1 2026.
- Quarterly Current Assets fell 9.15% year-over-year to $881.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $881.5 million (down 9.15% YoY) and the FY2025 annual result came in at $897.2 million, down 5.38% from the prior year.
- Current Assets was $881.5 million for Q1 2026 at Fortrea Holdings, down from $897.2 million in the prior quarter.
- Across five years, Current Assets topped out at $1.3 billion in Q3 2023 and bottomed at $881.5 million in Q1 2026.
- A 5-year average of $1.0 billion and a median of $960.0 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets decreased 27.92% — and 2025, when it climbed 8.14%.
- Fortrea Holdings' Current Assets stood at $1.2 billion in 2022, then climbed by 0.31% to $1.3 billion in 2023, then dropped by 24.19% to $948.2 million in 2024, then decreased by 5.38% to $897.2 million in 2025, then retreated by 1.75% to $881.5 million in 2026.
- Business Quant data shows FTRE's Current Assets at $881.5 million in Q1 2026, $897.2 million in Q4 2025, and $918.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 881.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 881.50 Mn |
| Dec 31, 2025 | 897.20 Mn |
| Sep 30, 2025 | 918.50 Mn |
| Jun 30, 2025 | 960.00 Mn |
| Mar 31, 2025 | 970.30 Mn |
| Dec 31, 2024 | 948.20 Mn |
| Sep 30, 2024 | 936.90 Mn |
| Jun 30, 2024 | 887.70 Mn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.25 Bn |